Severe active or active fistulising Crohn’s disease - historical notes
| Date | Note |
|---|---|
| 06/02/2025 | Addition of new amgevita formulations, ERWG Jan 24. |
| 22/10/2024 | Ustekinumab formulations added. ERFC Oct 2024. |
| 06/06/2024 | Addition of Risankizumab, ERFC DEC 23 |
| 16/11/2023 | Addition of Upadactinib SMC2575, Ustekinumab SMC1250/17 and Vedolizumab SMC1064/15 and SMC2277, ERFC August 2023. |
| 31/08/2023 | Removed 'Remsima 120mg/1ml solution for injection pre-filled syringes' as product discontinued. |
| 15/12/2021 | East Region Formulary content agreed. |